Abstract
The blood-optic nerve barrier is an important subject in any consideration of optic nerve and optic nerve head (ONH) vascular disorders. The capillaries in the ONH and the rest of the optic nerve, as in the retina [1–5] and in the central nervous system [6–10] have tight cell junctions between adjacent endothelial cells, without fenestration [11–13]. These tight junctions are responsible for the blood-optic nerve barrier, which has been shown by intravenous injection of tracer substances, such as horseradish peroxidase [14–16] and diaminoacridines [17].
For a complete bibliography and detailed review of previously published studies in the literature on the subject, please refer to bibliography in previous publications listed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cunha-Vaz JG, Shakib M, Ashton N. Studies on the permeability of the blood-retinal barrier. I. On the existence, development, and site of a blood-retinal barrier. Br J Ophthalmol. 1966;50(8):441–53.
Ishikawa T. Fine structure of retinal vessels in man and the Macaque monkey. Invest Ophthalmol. 1963;2:1–15.
Lasansky A, Wald F. The extracellular space in the toad retina as defined by the distribution of ferrocyanide: a light and electron microscope study. J Cell Biol. 1962;15(3):463–79.
Lasansky A. The pathway between hyaloid blood and retinal neurons in the toad. Structural observations and permeability to tracer substances. J Cell Biol. 1967;34(2):617–26.
Shakib M, Cunha-Vaz JG. Studies on the permeability of the blood-retinal barrier: IV. Junctional complexes of the retinal vessels and their role in the permeability of the blood-retinal barrier. Exp Eye Res. 1966;5(3):229–34.
Barber VC, Graziadei P. The fine structure of cephalopod blood vessels. 3. Vessel innervation. Z Zellforsch Mikrosk Anat. 1967;77(2):162–74.
Mugnaini E, Walberg F. The fine structure of the capillaries and their surroundings in the cerebral hemispheres of Myxine Glutinosa. Z Zellforsch Mikrosk Anat. 1965;66(3):333–51.
Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967;34(1):207–17.
Stensaas LJ, Stensaas SS. Astrocytic neuroglial cells, oligodendrocytes and microgliacytes in the spinal cord of the toad II. Electron microscopy. Z Zellforsch Mikrosk Anat. 1968;86(2):184–213.
Wolff E. Beiträge zur Ultrastruktur der Kapillaren ion der normalen Grosshirnrinde. Z Zellforsch Mikrosk Anat. 1963;60:409–31.
Anderson DR. Ultrastructure of meningeal sheaths. Normal human and monkey optic nerves. Arch Ophthalmol. 1969;82(5):659–74.
Anderson Dr. Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol. 1979;82(6):800–14.
Anderson DR, Hoyt WF. Ultrastructure of intraorbital portion of human and monkey optic nerve. Arch Ophthalmol. 1969;82(4):506–30.
Peyman CA, Apple D. Peroxidase diffusion processes in the optic nerve. Arch Ophthalmol. 1972;88(6):650–4.
Tso MOM, Shih C-Y, McLean IW. Is there a blood-brain barrier at the optic nerve head? Arch Ophthalmol. 1975;93(9):815–25.
Tsukahara I, Yamashita H. An electron microscopic study on the blood-optic nerve and fluid-optic nerve barrier. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;196(3):239–46.
Rodriguez-Peralta LA. Hematic and fluid barriers in the optic nerve. J Comp Neurol. 1966;126(1):109–21.
Olsson Y, Kristensson K. Permeability of blood vessels and connective tissue sheaths in retina and optic nerve. Acta Neuropathol. 1973;26(2):147–56.
Rodriguez-Peralta LA. The blood-optic nerve barrier. Anat Rec. 1963;145(2):277.
Okinami S, Ohkuma M, Tsukahara I. Kuhnt intermediary tissue as a barrier between the optic nerve and retina. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1976;201(1):57–67.
Cohen AI. Is there a potential defect in the blood-retinal barrier at the choroidal level of the optic nerve canal? Invest Ophthalmol. 1973;12(7):513–9.
Missotten L. Study of the capillaries of the retina and the choroid capillaries with the electron microscope. Ophthalmologica. 1962;144:1–12.
Spitznas M. Anatomical correlation of the normal fluoroangiography of the fundus. Doc Ophthalmol Proc Ser. 1976;9:177–80.
Grayson MC, Laties AM. Ocular localization of sodium fluorescein. Effects of administration in rabbit and monkey. Arch Ophthalmol. 1971;85(5):600–3 passim.
Tsukahara I, Ota M. Histological study on the distribution of sodium fluorescein in the fundus. Proceedings of the 4th Congress European Society of Ophthalmology. Budapest; 1972. Basel: Karger; 1974. p. 307–11.
Ben-Sira I, Riva CE. Fluorescein diffusion in the human optic disc. Invest Ophthalmol. 1975;14(3):205–11.
Laties AM, Rapoport S. The blood-ocular barriers under osmotic stress. Studies on the freeze-dried eye. Arch Ophthalmol. 1976;94(7):1086–91.
McMahon RT, Tso MO, McLean IW. Histologic localization of sodium fluorescein in human ocular tissues. Am J Ophthalmol. 1975;80(6):1058–65.
Davson H. The blood-brain barrier. In: Bourne GH, editor. The structure and function of nervous tissue, vol. IV. London: Academic; 1972. p. 321–445.
Beggs JL, Waggener JD. Transendothelial vesicular transport of protein following compression injury to the spinal cord. Lab Invest. 1976;34(4):428–39.
Beggs JL, Waggener JD, Miller W. Vasogenic edema in the injured spinal cord: possible role of microtubules in endothelial vasicular transport of HRP. In: Bailey GW, editor. Thirty-third Annual Proceedings of the Electron Microscopy Society of America. Baton Rouge: Claitor’s Publishing Division; 1975. p. 398–9.
Eto T, Omae T, Yamamoto T. An electron microscope study of hypertensive encephalopathy in the rat with renal hypertension. Arch Histol Jpn. 1971;33(2):133–43.
Reyners H, de Reyners EG, Jadin JM, Maisin JR. An ultrastructural quantitative method for the evaluation of the permeability to horseradish peroxidase of cerebral cortex endothelial cells of the rat. Cell Tissue Res. 1975;157(1):93–9.
Westergaard E. Enhanced vesicular transport of exogenous peroxidase across cerebral vessels, induced by serotonin. Acta Neuropathol. 1975;32(1):27–42.
Westergaard E. The effect of serotonin, norepinephrine and cyclic AMP on the blood-brain barrier. J Ultrastruct Res. 1975;50:383.
Westergaard E, Brightman MW. Transport of proteins across normal cerebral arterioles. J Comp Neurol. 1973;152(1):17–44.
Baumbach GL, Cancilla PA, Hayreh MS, Hayreh SS. Experimental injury of the optic nerve with optic disc swelling. Lab Invest. 1978;39:50–60.
Bruns RR, Palade GE. Studies on blood capillaries. II. Transport of ferritin molecules across the wall of muscle capillaries. J Cell Biol. 1968;37(2):277–99.
Hashimoto PH. Intracellular channels as a route for protein passage in the capillary endothelium of the shark brain. Am J Anat. 1972;134(1):41–57.
Hashimoto PH, Takaesu S, Chazono M, Amano T. Vascular leakage through intraendothelial channels induced by cholera toxin in the skin of guinea pigs. Am J Pathol. 1974;75(1):171–80.
Hirano A, Dembitzer HM, Becker NH, Levine S, Zimmerman HM. Fine structural alterations of the blood-brain barrier in experimental allergic encephalomyelitis. J Neuropathol Exp Neurol. 1970;29(3):432–40.
Simionescu N, Siminoescu M, Palade GE. Permeability of muscle capillaries to small heme-peptides. Evidence for the existence of patent transendothelial channels. J Cell Biol. 1975;64(3):586–607.
Machemer R. Angiographic-histologic correlation of eye vessel permeability with protein-bound fluorescent dye. Am J Ophthalmol. 1970;69(1):27–38.
Yamashita H, Miki H, Tsukahara I, Ogawa K. A histochemical study on the blood-optic nerve and fluid-optic nerve barrier. Acta Histochem Cytochem. 1973;6:163–9.
Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension V. Hypertensive optic neuropathy. Ophthalmology. 1986;93(1):74–87.
Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension VI. Hypertensive choroidopathy. Ophthalmology. 1986;93(11):1383–400.
Kishi S, Tso MOM, Hayreh SS. Fundus lesions in malignant hypertension I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol. 1985;103(8):1189–97.
Sossi N, Anderson DR. Blockage of axonal transport in optic nerve induced by elevation of intraocular pressure; effect of arterial hypertension induced by angiotensin I. Arch OphthalmoI. 1983;101(1):94–7.
Kishi S, Tso MOM, Hayreh SS. Fundus lesions in malignant hypertension II. A pathologic study of experimental hypertensive optic neuropathy. Arch Ophthalmol. 1985;103(8):1198–206.
Hayreh SS. Fluids in the anterior part of the optic nerve in health and disease. Surv Ophthalmol. 1978;23(1):1–25.
McLeod O, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J OphthalmoI. 1980;64(4):247–61.
Ashton N. The eye in malignant hypertension. Trans Am Acad Ophthalmol Otolaryngol. 1972;76(1):17–40.
Garner A, Ashton N, Tripathi R, et al. Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol. 1975;59(1):3–44.
Dollery CT. Hypertensive retinopathy. In: Genest J, Kuchel O, Hamet P, Cantin M, editors. Hypertension: physiopathology and treatment. 2nd ed. New York: McGraw-Hill; 1983. p. 723–32.
Hayreh MS, Hayreh SS, Baumbach GL, Cancilla P, Martin-Amat G, Tephly TR, et al. Methyl alcohol poisoning III. Ocular toxicity. Arch Ophthalmol. 1977;95(10):1851–8.
Hayreh SS. Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations and management. Ophthalmol Clin North Am. 1996;9(3):407–42.
Kaur C, Foulds WS, Ling EA. Blood–retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6):622–47.
Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, Ling EA. Blood–retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol. 2007;212(4):429–39.
Dobrogowska DH, Lossinsky AS, Tarnawski M, Vorbrodt AW. Increased blood–brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J Neurocytol. 1998;27(3):163–73.
Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol. 2004;187(2):388–402.
Mark KS, Burroughs AR, Brown RC, Huber JD, Davis TP. Nitric oxide mediates hypoxia-induced changes in paracellular permeability of cerebral microvasculature. Am J Physiol Heart Circ Physiol. 2004;286(1):H174–80.
Mayhan WG. VEGF increases permeability of the blood–brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol. 1999;276(5 Pt 1):C1148–53.
Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2002;63(1):70–80.
Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002;125(Pt 11):2549–57.
Kaur C, Sivakumar V, Foulds WS. Early response of neurons and glial cells to hypoxia in the retina. Invest Ophthalmol Vis Sci. 2006;47(3):1126–41.
Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma. 1994;11(3):289–301.
Hirano A, Kawanami T, Llena JF. Electron microscopy of the blood–brain barrier in disease. Microsc Res Tech. 1994;27(6):543–56.
Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, et al. Correlation of VEGF and angiopoietin expression with disruption of blood–brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002;22(4):379–92.
Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225–30.
Spoerri PE, Afzal A, Li Calzi S, Shaw LC, Cai J, Pan H, et al. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells. Mol Vis. 2006;12:32–42.
Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: fundamentals and clinical practice. St. Louis: Mosby; 1996.
Cunningham Jr ET, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D’Amico DJ, et al. Macugen Diabetic Retinopathy Study Group. A phase II randomised double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005;112(10):1747–57.
Hayreh SS, Zimmerman MB. Optic disc edema in non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245(8):1107–21.
Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246(7):1029–46.
Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye. 2004;18(11):1188–206.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hayreh, S.S. (2011). Blood-Optic Nerve Barrier. In: Ischemic Optic Neuropathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11852-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-11852-4_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11849-4
Online ISBN: 978-3-642-11852-4
eBook Packages: MedicineMedicine (R0)